Covid US: Pfizer and Moderna expand vaccine clinical trials in children aged 5-11
Pfizer-BioNTech and Moderna are expanding the sizes of their COVID-19 vaccine clinical trials in children ages five to 11 at the urging of the U.S. Food and Drug Administration (FDA).
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: Children | Clinical Trials | COVID-19 | Food and Drug Administration (FDA) | Health | Pfizer | Vaccines